4D Pharma PLC Warrant
LBPSW
LBPSW was delisted on the 29th of June, 2022.
5 hedge funds and large institutions have $506K invested in 4D Pharma PLC Warrant in 2021 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 3 closing their positions.
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
38% less funds holding
Funds holding: 8 → 5 (-3)
58% less capital invested
Capital invested by funds: $1.19M → $506K (-$685K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BFM
Boothbay Fund Management
New York
|
+$1.03K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KPF
K2 Principal Fund
Toronto,
Ontario, Canada
|
-$601K |
| 2 |
AA
AQR Arbitrage
Greenwich,
Connecticut
|
-$35.6K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$5K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
BFM
1
Boothbay Fund Management
New York
| $298K | +$1.03K | +1,025 | +4% |
|
|
AA
2
AQR Arbitrage
Greenwich,
Connecticut
| $88K | -$35.6K | -35,351 | -28% |
|
|
HF
3
HRT Financial
New York
| $65K | – | – | – |
|
|
YCM
4
Yakira Capital Management
Westport,
Connecticut
| $49K | – | – | – |
|
|
HIM
5
HGC Investment Management
Toronto,
Ontario, Canada
| $6K | – | – | – |
|
|
KPF
6
K2 Principal Fund
Toronto,
Ontario, Canada
| – | -$601K | -550,944 | Closed |
|
|
7
UBS Group
Zurich,
Switzerland
| – | -$5K | -4,845 | Closed |
|
LBPSW Hedge Fund Activity: Q2 2021 in Review
5 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in 4D Pharma PLC Warrant (LBPSW) for Q2 2021, worth a combined $506K — down 58% from $1.19M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of LBPSW and 0 opened new positions — a net loss of 3 holders — while 1 trimmed existing stakes and 1 added.
The largest buyer was Boothbay Fund Management, adding an estimated $1.03K. The largest seller was K2 Principal Fund, exiting entirely with an estimated $601K sold.
- 5 institutional investors held 4D Pharma PLC Warrant (LBPSW) as of Q2 2021, down from 8 in Q1 2021.
- Funds reported $506K of 4D Pharma PLC Warrant stock for Q2 2021, down 58% quarter-over-quarter.
- 0 funds opened new 4D Pharma PLC Warrant positions in Q2 2021 and 3 closed out, a net change of -3 holders.
- The largest 4D Pharma PLC Warrant buyer in Q2 2021 was Boothbay Fund Management, an estimated $1.03K added.
- The largest 4D Pharma PLC Warrant seller in Q2 2021 was K2 Principal Fund, an estimated $601K sold.
Based on aggregated 13F filings for Q2 2021.